Laupan, Homaira .
HRN: 20-65-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2024
CEFUROXIME 500MG (TAB)
07/12/2024
07/18/2024
PO
1 Tab
BiD
NSVD With Perineorrhaphy
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes